Alpha 2.0
Login Register
» Articles » PMID: 11363011

FDA Approves 3TC and Saquinavir. Food and Drug Administration

Overview
Journal BETA
Specialties Infectious Diseases
Pharmacology
Date 1995 Dec 1
PMID 11363011
Citations 6
Authors
R Baker
Affiliations
Soon will be listed here.
Citing Articles

The reverse transcriptase inhibitor 3TC modulates hippocampal transcriptome signatures of inflammation in tauopathy model mice.

Wahl D, Grant R, LaRocca T Exp Gerontol. 2024; 192:112458.

PMID: 38735597 PMC: 11185825. DOI: 10.1016/j.exger.2024.112458.

Liposomal Delivery of Saquinavir to Macrophages Overcomes Cathepsin Blockade by and Helps Control the Phagosomal Replicative Niches.

Pires D, Mandal M, Pinho J, Catalao M, Almeida A, Azevedo-Pereira J Int J Mol Sci. 2023; 24(2).

PMID: 36674655 PMC: 9863908. DOI: 10.3390/ijms24021142.

Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection.

Pires D, Valente S, Calado M, Mandal M, Azevedo-Pereira J, Anes E Front Immunol. 2021; 12:647728.

PMID: 33841429 PMC: 8032898. DOI: 10.3389/fimmu.2021.647728.

Enhancement of saquinavir absorption and accumulation through the formation of solid drug nanoparticles.

Kigen G, Edwards G BMC Pharmacol Toxicol. 2018; 19(1):79.

PMID: 30509316 PMC: 6278041. DOI: 10.1186/s40360-018-0275-5.

Therapeutic Approaches for Zika Virus Infection of the Nervous System.

Abrams R, Solis J, Nath A Neurotherapeutics. 2017; 14(4):1027-1048.

PMID: 28952036 PMC: 5722777. DOI: 10.1007/s13311-017-0575-2.